Zika Virus Vaccines

The Live-Attenuated vaccine is produced to the disease caused by Zika Virus. The monovalent form of the antibody is outlined against Zika infection contamination. Zika Virus has a place with the Genus Flavivirus, or, in other words the Aedes mosquitos. The comprehension of flavivirus molecule structure, meaning of E dimers as the key antigenic target, and profound comprehension of balance systems help to build up the antibody.


  • Zika Virus Vaccines Clinical Trials
  • Zika Virus Vaccine Development
  • Zika Virus Vaccines Recent Research
  • Zika Virus Vaccines Recent Research
  • Purified Inactivated Vaccine

Related Conference of Zika Virus Vaccines

March 26-27, 2021

10th World Conference on Earth & Environmental Science

Edinburgh, Scotland
April 06-07, 2021

9th World Climate Congress & Expo

Bangkok, Thailand
May 17-18, 2021

Global Virtual Summit on Environmental Health

New York, USA
May 17-18, 2021

37th World Vaccines & Immunization Congress

Bangkok, Thailand
May 27-28, 2021

2nd Annual Congress on Biofuels and Biopolymers

Vancouver, Canada
July 28-29, 2021

9th World Congress and Expo on Green Energy

London, UK
July 28-29, 2021

13th World Congress and Expo on Recycling

London, UK
August 23-24, 2021

9th Global Summit and Expo on Pollution Control

Prague, Czech Republic
September 13-14, 2021

19th Global Recycling Expo

London, UK
September 13-14, 2021

12th World Climate Change Conference

London, UK
September 21-22, 2021

9th World Climate Change Congress

Kyoto, Japan
September 24-25, 2021

10th Environmental Science and Pollution Control

Tokyo, Japan
October 18-19, 2021

10th World Conference on Climate Change

Rome, Italy
October 26-27, 2021

4th World Congress on Environmental Toxicology

Osaka, Japan
December 13-14, 2021

18th World Congress on Recycling & E-waste Management

Toronto, Canada

Zika Virus Vaccines Conference Speakers

Recommended Sessions

Related Journals

Are you interested in